1 |
Gupta NC, Tamin WJ, Graeber GG, Bishop HA, Hobbs GR. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 2001;120:521-27
DOI
ScienceOn
|
2 |
Hoffman H. Invasive staging of lung cancer by mediastinoscopy and video-assisted thoracoscopy. Lung Cancer 2001;34: S3-5
|
3 |
Berghmans T, Paesmans M, Meert AP, et al. Survival improvement in resectable non-small cell lung cancer with (neo) adjuvant chemotherapy: reults of a meta-analysis of the literature. Lung Cancer 2005;49:13-23
DOI
ScienceOn
|
4 |
Kimura H, Iwai N, Ando A, et al. A prospective study of indications for mediastinoscqry in lung cancer with CT findings, tumor size, and tumor markers. Ann Thorac Surg 2003;75:1734-9
DOI
ScienceOn
|
5 |
Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovsc Surg 1978;76:833-9
|
6 |
De Leyn P, Vansteenkiste J, Cuypers P, et al. Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg 1997;12:706-12
DOI
ScienceOn
|
7 |
Venissac N, Alifano M, Mouroux J. Video-assisted mediastinoscopy: experience fran 240 consecutive cases. Ann Thorac Surg 2003;76:208-12
DOI
ScienceOn
|
8 |
Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IlIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 1999;47:7-14
|
9 |
Mountain CF. Revisions in the internaional system for staging lung cancer. Chest 1997;111:1710-17
DOI
ScienceOn
|
10 |
Hammoud ZT, Anderson RC, Meyers BF, et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg 1999;118:894-9
DOI
ScienceOn
|
11 |
Kramer H, Groen HJM. Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer. Ann Surg 2003;238:180-88
|
12 |
Smolders SA, Smeenk F, Janssen-Heijen M, et al. Surgical mediastinal staging in daily practice. Lung Cancer 2005;47: 243-51
DOI
ScienceOn
|
13 |
Betticher DC, Schmiz SFH, Totsh M, et al. Mediastinal lymph node clearance after Doxetaxel-Cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 2003;21:1752-9
DOI
ScienceOn
|
14 |
Port JL, Karst RJ, Lee PC, et al. Surgical resection for residual N2 disease after induction chemotherapy. Ann Thorac Surg 2005;79:1686-90
DOI
ScienceOn
|
15 |
Pieterman RM, van Putten JWG, Meuzelaar JJM, et al. Preoperative staging of non-small cell lung cancer with positronemission tomography. N Engl J Med 200;343:254-61
DOI
ScienceOn
|
16 |
Cerfolio R, Ojha B, Bryant AS, et al. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg 2003;76:861-6
DOI
ScienceOn
|